Filing of PCT for proprietary 3D printing platform for Drug Discovery and Development
ReaGene Biosciences announces filing of PCT for its proprietary 3D printing platform for Drug Discovery and Development.
Collaboration with Issar Pharma
Reagene collaborates with Issar on novel therapies for sepsis using their 3D bioprinted technology.